1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Ventas
  6. News
  7. Summary
    VTR   US92276F1003

VENTAS

(VTR)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Ventas Announces Fourth Quarter 2021 Earnings Release Date and Conference Call

01/24/2022 | 04:50pm EDT

Ventas, Inc. (NYSE: VTR) will issue its fourth quarter 2021 earnings release after the close of trading on the New York Stock Exchange on Thursday, February 17, 2022. A conference call to discuss those earnings will be on Friday, February 18, 2022 at 10:00 a.m. Eastern Time (9:00 a.m. Central Time).

The dial-in number for the conference call is (888) 330-3576 (or +1 (646) 960-0672 for international callers), and the participant passcode is 7655497. A live webcast can be accessed from the Investor Relations section of www.ventasreit.com.

A telephonic replay will be available at (800) 770-2030 (or +1 (647) 362-9199 for international callers), passcode 7655497, after the earnings call and will remain available for 30 days. The webcast replay will be posted in the Investor Relations section of www.ventasreit.com.

About Ventas

Ventas Inc., an S&P 500 company, operates at the intersection of two large and dynamic industries – healthcare and real estate. Fueled by powerful demographic demand from growth in the aging population, Ventas owns a diversified portfolio of over 1,200 properties in the United States, Canada and the United Kingdom. Ventas uses the power of its capital to unlock the value of senior living communities; life science, research & innovation properties; medical office & outpatient facilities, health systems and other healthcare real estate. A globally-recognized real estate investment trust, Ventas follows a successful long-term strategy, proven over more than 20 years, built on diversification of property types, capital sources and industry leading partners, financial strength and flexibility, consistent and reliable growth and industry leading ESG achievements, managed by a collaborative and experienced team dedicated to its stakeholders.


© Business Wire 2022
All news about VENTAS
05/20RBC Lifts Price Target on Ventas to $63 From $62, Maintains Outperform Rating
MT
05/19Ventas Named a Top Corporate Citizen of 2022 by 3BL Media
BU
05/18Ventas's Outlook Revised by S&P Global Ratings to Stable
BU
05/18Credit Suisse Upgrades Ventas to Outperform from Neutral, Expects Outsized Earnings Gro..
MT
05/18WALL STREET STOCK EXCHANGE : Powell and Target dampen the mood
05/18ANALYST RECOMMENDATIONS : Reckitt, Home Depot, Penn National, Walmart, WH Smith...
05/11Ventas to Participate in Investor Meetings at BMO 2022 Real Estate Summit
BU
05/11Ventas Earns 2022 ENERGY STAR® Partner of the Year, Energy Management Award
BU
05/06VENTAS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS O..
AQ
05/06TRANSCRIPT : Ventas, Inc., Q1 2022 Earnings Call, May 06, 2022
CI
More news
Analyst Recommendations on VENTAS
More recommendations
Financials (USD)
Sales 2022 4 181 M - -
Net income 2022 69,0 M - -
Net Debt 2022 11 484 M - -
P/E ratio 2022 293x
Yield 2022 3,26%
Capitalization 22 591 M 22 591 M -
EV / Sales 2022 8,15x
EV / Sales 2023 7,55x
Nbr of Employees 434
Free-Float 99,5%
Chart VENTAS
Duration : Period :
Ventas Technical Analysis Chart | VTR | US92276F1003 | MarketScreener
Technical analysis trends VENTAS
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Last Close Price 56,52 $
Average target price 63,93 $
Spread / Average Target 13,1%
EPS Revisions
Managers and Directors
Debra A. Cafaro Chairman & Chief Executive Officer
Robert F. Probst Chief Financial Officer & Executive Vice President
Bhavana Devulapally Chief Information Officer & Senior Vice President
Carey S. Roberts EVP, General Counsel, Ethics & Compliance Officer
John D. Cobb Chief Investment Officer & Executive VP
Sector and Competitors
1st jan.Capi. (M$)
VENTAS10.56%22 591
WELLTOWER INC.2.73%39 999
HEALTHPEAK PROPERTIES, INC.-18.48%15 874
MEDICAL PROPERTIES TRUST, INC.-23.53%10 844
OMEGA HEALTHCARE INVESTORS, INC.-2.84%6 762
HEALTHCARE TRUST OF AMERICA, INC.-13.39%6 625